Healthcare reforms, shifting market demands, and increasing regulatory pressures are transforming the pharmaceutical industry on a global scale.
From large multinational pharmaceutical organisations to biotech companies and contract research organisations, every business has its own unique challenges. However, there are recurring risks and pain points common to all.
How you respond to them will determine your future profitability and success.
Business issues and challenges

 Business issues and challenges

As worldwide drug spending changes, companies need to find new ways to reach global populations safely and cost-effectively. However, local and regional regulations – which impact everything from labelling, packaging, and pricing – need to be taken into account.

Patent expirations are putting pressure on many of the major industry players. Once established products go off-patent, they can be replicated and sold by generic product manufacturers at much lower prices.

Mergers, acquisitions and portfolio sell-offs are commonplace in the industry. These often require the consolidation and standardisation of resources and governance processes.

Despite sustained investments in research and development (R&D), it’s taking longer than ever for pharmaceutical organisations to find new drugs. Growing failure rates of R&D and increased difficulty in gaining regulatory approval for new drugs, only exacerbate the problem.

Meanwhile, today’s patients expect a faster, more personal service experience, delivered through the channel of their choice. However, as you adopt cloud, social media, and mobile technologies, your organisation will need to fend off potential new security threats and breaches.

 A Partner who can help

​Dimension Data understands that to keep pace with this industry transformation, you need to reduce your overall cost base and innovate your operating model. You also need to explore global expansion opportunities, and consider new business models and opportunities for joint ventures with traditional competitors. 


To help you make this transition, we offer a range of technology, services, and solutions that cover your networking, data centre, customer experience and collaboration, security, and end-user computing environments.



 Dimension Data’s Security Certifications can assist validation efforts to achieve compliance with the FDA's CFR Title 21 Part 11

CFR Title 21 Part 11 sets forth the criteria under which the FDA considers electronic records, electronic signatures, and handwritten signatures executed to electronic records to be trustworthy, reliable, and generally equivalent to paper records and handwritten signatures executed on paper. This regulation, which applies to all FDA program areas, is intended to permit the widest possible use of electronic technology, compatible with FDA’s responsibility to protect the public health.

Dimension Data’s Public Infrastructure-as-a-Service (Public Cloud), Private IaaS (Private Cloud), Managed Hosting, Enterprise Mobility-as-a-Service, Cloud Private Network Connection, Security Operations Centre and Cloud Services for Microsoft have all been certified by independent, third-party auditors according to international information security standards ISO 27001:2013 (with specific inclusion of the privacy controls of ISO 27018), CSA-STAR, and SOC 1 SSAE 16 Type 2.



  • Dimension Data accelerates the ambition of the pharmaceutical industry

    The pharmaceutical industry is in synthesis. Take two minutes to listen to us share some thoughts and client examples about how technology can enable you to respond to today’s challenges.

Latest Thinking


What our clients say

 What our clients say

  • Streamlined, Consolidated ICT Maintenance Helps Pharmaceutical Giant Sustain the Pace of Innovation
    The manufacturer was able to reduce its security team from 24 people to only four or five in each of its lines of business.

    Read more

  • Global pharmaceutical manufacturer saves 20% by matching IT support levels to business criticality
    By aligning IT services with business criticality, the organisation reduced its IT cost base and was able to invest in innovative technology to drive further growth.

    Read more

  • Pharmaceutical manufacturer ensures steady supply of lifesaving medicine thanks to reliable IT network
    With stronger support and maintenance, the manufacturer is ensured of a corporate network that’s always available, which improves business continuity and negates revenue losses.

    Read more

  • Aspen Pharmacare improves global communication with worldwide video conferencing solution
    Within a few months of go-live, millions of precisely tracked travel miles and man travel hours had been avoided, saving Africa’s largest pharmaceutical manufacturer millions of rands in costs.

    Read more

Our skills and expertise

 Our services include:

Platform consolidation

We assist you to centralise, consolidate, and re-platform your legacy computing environment.

Global expansion and footprint rationalisation

Global expansion into new and emerging markets can bring opportunities… and challenges. The complexities of running a multinational business can drain valuable resources and expose you to undue risk.

Mergers and acquisitions bring a range of technology-related challenges including data, systems, real estate consolidation, and security. We help you to reduce the scale of your IT operations and minimise the amount of physical space and power you use – thereby saving costs and eliminating post-merger and acquisition excesses.

Delivery model innovation

You need to harness the power of technology to drive innovation and growth, support the introduction of new products, and reduce costs within your R&D environment. We’ll work with you to redesign and optimise your delivery model and exploit the capability to deliver IT as a service.


Security and regulatory compliance

As cyberthreats continue to disrupt business in the digital world, we assist you to reduce risk and ensure that your IT infrastructure and operations meet audit and compliance guidelines by ensuring that you have visibility of activities and potential risks you might be facing.


End-user computing solutions

Given the heightened levels of competition in the industry, you need to sharpen your distribution and marketing efforts. This includes optimising collaboration internally as well as with partners, doctors, and patients, and ensuring you have the latest end-user technology to enable your mobile sales teams.



Success in today’s competitive marketplace requires the ability to turn information into actionable intelligence and optimise the effectiveness of your research and development function. You also need to enable better collaboration between multiple internal research teams and with external contract research organisations.

Contact us

 Contact us if you have any questions